Lawrence Lai
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Monoclonal and Polyclonal Antibodies Research
- Medical Imaging Techniques and Applications
- Oncology top 10%
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 4
- Radiopharmaceutical Chemistry and Applications 3
- Surgery 3
- Co-authors
- David A. Scheinberg (5 shared papers)Dangshe Ma (3 shared papers)Michael Curcio (2 shared papers)Neil H. Bander (2 shared papers)Michael R. McDevitt (2 shared papers)Matthias Miederer (1 shared paper)Karen Wu (1 shared paper)R. Keith Frank (1 shared paper)
- Journals
- JNCI Journal of the National Cancer Institute (1 paper)Journal of Clinical Microbiology (1 paper)Leukemia (1 paper)Blood (1 paper)Science (1 paper)
- Partner nations
- United StatesPuerto RicoDenmark
In The Last Decade
Lawrence Lai
12 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 92
- Radiology, Nuclear Medicine and Imaging 503
- Oncology 329
- Hematology 128
- Immunology 180
- Pulmonary and Respiratory Medicine 214
Countries citing papers authored by Lawrence Lai
This map shows the geographic impact of Lawrence Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence Lai more than expected).
Fields of papers citing papers by Lawrence Lai
This network shows the impact of papers produced by Lawrence Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence Lai. The network helps show where Lawrence Lai may publish in the future.
Co-authors
The 25 scholars most cited alongside Lawrence Lai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 382 | |
| 2 | An alpha-particle emitting antibody ([213Bi]J591) for radioimmunotherapy of prostate cancer. | 2000 | 215 |
| 3 | 2000 | 195 | |
| 4 | 1995 | 105 | |
| 5 | 1995 | 79 | |
| 6 | Antitumor activity of actinonin in vitro and in vivo. | 1998 | 55 |
| 7 | 2002 | 39 | |
| 8 | 2012 | 39 | |
| 9 | Interleukin-2 enhancement of cytotoxicity by humanized monoclonal antibody M195 (anti-CD33) in myelogenous leukemia. | 1995 | 34 |
| 10 | 1997 | 23 | |
| 11 | 2009 | 22 | |
| 12 | 1993 | 2 |
About Lawrence Lai
Lawrence Lai is a scholar working on Radiology, Nuclear Medicine and Imaging, Surgery, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Oncology, having authored 12 papers that have together received 1.2k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers), Chronic Myeloid Leukemia Treatments (2 papers), Pancreatic and Hepatic Oncology Research (1 paper), Toxoplasma gondii Research Studies (1 paper), Radiation Therapy and Dosimetry (1 paper), Immunotherapy and Immune Responses (1 paper) and Fatty Acid Research and Health (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (503 citations), Oncology (329 citations), Hematology (128 citations), Immunology (180 citations) and Pulmonary and Respiratory Medicine (214 citations). Lawrence Lai has collaborated with scholars based in United States, Puerto Rico and Denmark. Frequent co-authors include David A. Scheinberg, Dangshe Ma, Michael Curcio, Neil H. Bander, Michael R. McDevitt, Matthias Miederer, Karen Wu, R. Keith Frank, Jim Simón and Paul E. Borchardt. Their work appears in journals such as JNCI Journal of the National Cancer Institute, Journal of Clinical Microbiology, Leukemia, Blood and Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.